EisnerAmper announced the following leadership appointments within its Technology and Life Sciences Services Group, effective January 1, 2021.
 
Marc Fogarty: National Biotech Sector Leader - Marc is an audit partner with more than 20 years of experience serving public and private organizations, focusing on those in the biotech industry. He has specific experience assisting his clients with business consulting, concentrating on improving operational efficiency and profitability.  
 
Michael Hadjiloucas: National Pharmaceutical & Medical Devices Sector Leader - With nearly 30 years of experience, Michael has earned an outstanding reputation in the pharmaceutical and medical devices community. As the partner-in-charge of the firm’s Corporate Tax Group, he also has extensive experience with the review of corporate, partnership, individual and tax-exempt entity tax returns, and representation in federal and state audits.  
   
Richard Cleaveland: National Software Sector Leader - As an audit partner with 25 years of experience, Rich has significant expertise advising public and private software companies in areas such as revenue recognition, business combinations, capital transactions, risk and controls, and equity-based compensation. He also frequently speaks and contributes to the media relating to software and venture-funded companies.  
 
Jon Zefi: National Technology Services Sector Leader - With more than 15 years of experience serving technology companies, Jon is a principal and member of the Tax Advisory Services Group. He represents clients in domestic and international corporate reorganizations, acquisitions and divestitures, joint ventures and technology transfers, and private equity and investment funds.
 
“Each of these highly skilled professionals has vast experience in their respective specialties, and our life sciences and technology clients will benefit greatly from their leadership,” said Jay Weinstein, Vice Chair of Industries and Markets.

Added John Pennett, Partner-in-Charge of the firm’s Technology and Life Sciences Group: “Many sectors are undergoing significant growth, and we’re confident that the knowledge and experience of these leaders will take our practice groups to the next level.”